Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid
Previous mass spectrometry analysis of cerebrospinal fluid (CSF) has allowed the identification of a panel of molecular markers that are associated with Alzheimer's disease (AD). The panel comprises Amyloid beta, Apolipoprotein E, Fibrinogen alpha chain precursor, Keratin type I cytoskeletal 9,...
Main Authors: | Richens, J, Vere, K, Light, R, Smith, A, al., E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
e-Century Publishing
2014
|
Similar Items
-
Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid.
by: Vafadar-Isfahani, B, et al.
Published: (2012) -
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease
by: Ahmad, S, et al.
Published: (2020) -
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
by: Bos, I, et al.
Published: (2019) -
Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
by: Tapiola, T, et al.
Published: (2009) -
Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers
by: Nho, K, et al.
Published: (2019)